KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Charles River Laboratories International (CRL) Net Income towards Common Stockholders: 2009-2025

Historic Net Income towards Common Stockholders for Charles River Laboratories International (CRL) over the last 17 years, with Sep 2025 value amounting to $54.4 million.

  • Charles River Laboratories International's Net Income towards Common Stockholders fell 20.76% to $54.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$83.5 million, marking a year-over-year decrease of 120.21%. This contributed to the annual value of $10.3 million for FY2024, which is 97.83% down from last year.
  • Latest data reveals that Charles River Laboratories International reported Net Income towards Common Stockholders of $54.4 million as of Q3 2025, which was up 4.01% from $52.3 million recorded in Q2 2025.
  • Charles River Laboratories International's 5-year Net Income towards Common Stockholders high stood at $189.1 million for Q4 2022, and its period low was -$215.7 million during Q4 2024.
  • Its 3-year average for Net Income towards Common Stockholders is $56.1 million, with a median of $68.7 million in 2024.
  • Per our database at Business Quant, Charles River Laboratories International's Net Income towards Common Stockholders surged by 48.94% in 2022 and then slumped by 215.30% in 2024.
  • Over the past 5 years, Charles River Laboratories International's Net Income towards Common Stockholders (Quarterly) stood at $139.8 million in 2021, then surged by 35.24% to $189.1 million in 2022, then fell by 1.07% to $187.1 million in 2023, then plummeted by 215.30% to -$215.7 million in 2024, then fell by 20.76% to $54.4 million in 2025.
  • Its Net Income towards Common Stockholders was $54.4 million in Q3 2025, compared to $52.3 million in Q2 2025 and $25.5 million in Q1 2025.